Patients must provide study specific informed consent prior to study entry, including consent for mandatory tissue submission for EGFR and for oropharyngeal patients, HPV analysesXx_NEWLINE_xXPatients must provide study specific informed consent prior to study entry, including consent for mandatory tissue submission for central reviewXx_NEWLINE_xXPatient must provide study specific informed consent prior to study entry, including consent for mandatory tissue submission for epidermal growth factor receptor (EGFR) analysis and for oropharyngeal cancer patients, human papilloma virus (HPV) analysisXx_NEWLINE_xXPatient must provide study specific informed consent prior to study entry, including consent for mandatory screening of tissueXx_NEWLINE_xXPatient must provide study specific informed consent prior to study entry, including the mandatory pre-treatment plasma EBV DNA assayXx_NEWLINE_xXThe patient or a legally authorized representative must provide study-specific informed consent prior to study entry, including consent for mandatory tumor tissue, serum, and blood submission for immune correlatives (all patients) and p16 analysis (oropharyngeal cases only)Xx_NEWLINE_xX